Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;25(2):291-310.
doi: 10.1016/j.cld.2021.01.003. Epub 2021 Mar 10.

Prevention of First Decompensation in Advanced Chronic Liver Disease

Affiliations
Free article
Review

Prevention of First Decompensation in Advanced Chronic Liver Disease

Mattias Mandorfer et al. Clin Liver Dis. 2021 May.
Free article

Abstract

The first occurrence of decompensation constitutes a watershed moment in the natural history of chronic liver disease; it denotes a point of no return in a relevant proportion of patients. Preventive strategies may profoundly decrease cirrhosis-related morbidity and mortality. Removing the primary etiologic factor and cofactors, is key; however, a considerable proportion of patients require additional etiology-independent treatment strategies that target important pathomechanisms promoting decompensation (ie, portal hypertension and systemic inflammation). This article explains the importance of preventing first decompensation and summarizes the evidence for etiologic and etiology-independent (most important, nonselective beta-blockers and statins) therapies.

Keywords: ACLD; Ascites; Cirrhosis; Fibrosis; Hepatic encephalopathy; Inflammation; Portal hypertension; Variceal bleeding.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement M. Mandorfer served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Collective Acumen, Gilead, and W. L. Gore & Associates and received travel support from AbbVie, Bristol-Myers Squibb, and Gilead. B. Simbrunner received travel support from AbbVie and Gilead.

LinkOut - more resources